ImmuCell Corporation Operating Lease Right-of-Use Assets
ImmuCell Corporation (ICCC) had Operating Lease Right-of-Use Assets of $4.39 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $4.39M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $4.34M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $4.38M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $4.42M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $4.39M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.34M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.38M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $4.42M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $4.54M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $4.53M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.56M 10-K · filed 2026-03-30 |
| 2024-09-30 | $4.59M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $4.50M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $4.55M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.57M 10-K · filed 2025-03-28 |
| 2023-09-30 | $4.22M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $4.28M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.18M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.19M 10-K · filed 2024-04-01 |
| 2022-09-30 | $2.22M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $1.05M 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $1.08M 10-Q/A · filed 2022-11-21 |
| 2021-12-31 | $1.11M 10-K · filed 2023-03-29 |
| 2021-09-30 | $1.14M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.16M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.19M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.22M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.25M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.28M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.31M 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |